DS
CORZ icon

David Shaw’s Core Scientific CORZ Stock Holding History

David Shaw’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.6M Buy
3,345,544
+3,284,211
+5,355% +$77.3M 0.04% 513
2026
Q1 		$918K Sell
61,333
-167,211
-73% -$2.85M ﹤0.01% 3495
2025
Q4 		$3.33M Sell
228,544
-4,809,906
-95% -$83.9M ﹤0.01% 2646
2025
Q3 		$90.4M Buy
5,038,450
+439,826
+10% +$6.45M 0.05% 430
2025
Q2 		$78.5M Buy
4,598,624
+1,748,662
+61% +$17.5M 0.06% 398
2025
Q1 		$20.6M Buy
2,849,962
+2,154,292
+310% +$24.5M 0.02% 928
2024
Q4 		$9.77M Buy
+695,670
New +$10.3M 0.01% 1519

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

David Shaw's CORZ Position: Q2 2026 in Review

David Shaw increased its Core Scientific (CORZ) stake by 5,355% in Q2 2026, buying an estimated $77.3M and bringing the position to 3,345,544 shares worth $85.6M. The position accounts for 0.04% of the portfolio, ranked #513.

David Shaw first reported a position in CORZ in Q4 2024 and has held it in 7 quarters since. The position peaked at $90.4M in Q3 2025. 411 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • David Shaw held 3,345,544 shares of Core Scientific worth $85.6M as of Q2 2026.
  • David Shaw bought 3,284,211 Core Scientific shares in Q2 2026, an estimated $77.3M.
  • Core Scientific made up 0.04% of David Shaw's portfolio in Q2 2026, its #513 holding.
  • David Shaw first reported a position in Core Scientific in Q4 2024 and has held it in 7 quarters since.
  • David Shaw's Core Scientific position peaked at $90.4M in Q3 2025.
  • 411 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.